EUVIMEDEUVIMED entdecken
Open Access

SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation

Lingxiang Lu, Ke Wu, Zhenfan Wang, Ruoxi Yang, Kai Li, Shuai Guo, Fei Wang, Zheng Ma

Oncology Reports · 13.05.2026 · 56 (1) · 1-14

DOI: 10.3892/or.2026.9134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 13.05.2026. Verfasst von Lingxiang Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Suzhou Ninth People's Hospital, Soochow University, Suzhou, Jiangsu 215000, P.R. China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Prostatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorProstatic NeoplasmsBiomarkers, TumorMaleHumansPrognosisAnimalsSignal TransductionDisease ProgressionMiceGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorCell MovementUp-Regulation

Stichwörter der Autor:innen

SRRTSTAT3 signaling pathwaybiomarkerprostate adenocarcinoma

Substanzen

STAT3 Transcription FactorSTAT3 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Suzhou Ninth People's Hospital, Soochow University, Suzhou, Jiangsu 215000, P.R. China.
  • Department of Urology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215000, P.R. China.
  • School of Medicine, Tongji University, Shanghai 200000, P.R. China.

Zitieren

APA

Lu, L., Wu, K., Wang, Z., Yang, R., Li, K., Guo, S., Wang, F., & Ma, Z. (2026). SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation. Oncology Reports, 56(1), 1-14. https://doi.org/10.3892/or.2026.9134

Vancouver

Lu L, Wu K, Wang Z, Yang R, Li K, Guo S, et al. SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation. Oncology Reports. 2026;56(1):1-14. doi:10.3892/or.2026.9134

BibTeX
@article{Lu2026,
  author = {Lu, Lingxiang and Wu, Ke and Wang, Zhenfan and Yang, Ruoxi and Li, Kai and Guo, Shuai and Wang, Fei and Ma, Zheng},
  title = {SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation},
  journal = {Oncology Reports},
  year = {2026},
  volume = {56},
  number = {1},
  pages = {1--14},
  doi = {10.3892/or.2026.9134}
}
Kostenlos starten →